Methylprednisolone and Graves' ophthalmopathy.
作者信息
Dandona P, Havard C W, Mier A
出版信息
BMJ. 1989 Mar 25;298(6676):830. doi: 10.1136/bmj.298.6676.830.
Abstract
摘要
相似文献
1
Methylprednisolone and Graves' ophthalmopathy.甲泼尼龙与格雷夫斯眼病
BMJ. 1989 Mar 25;298(6676):830. doi: 10.1136/bmj.298.6676.830.
2
Methylprednisolone in the treatment of exophthalmos.甲基强的松龙治疗突眼症
Lancet. 1966 Apr 30;1(7444):958-60. doi: 10.1016/s0140-6736(66)90954-8.
3
High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.大剂量静脉注射皮质类固醇疗法治疗格雷夫斯眼病。
J Endocrinol Invest. 2001 Mar;24(3):152-8. doi: 10.1007/BF03343835.
4
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.使用[111铟-二乙烯三胺五乙酸-D-苯丙氨酸1]-奥曲肽进行眼眶闪烁扫描可预测格雷夫斯眼病患者对皮质类固醇治疗的临床反应。
J Clin Endocrinol Metab. 1998 Nov;83(11):3790-4. doi: 10.1210/jcem.83.11.5274.
5
Early effects of methylprednisolone infusion on serum cystatin C in patients with severe Graves' ophthalmopathy.甲泼尼龙输注对重度格雷夫斯眼病患者血清胱抑素C的早期影响。
Clin Chim Acta. 2005 Jun;356(1-2):227-8. doi: 10.1016/j.cccn.2005.01.022. Epub 2005 Mar 17.
6
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.静脉注射或口服糖皮质激素联合眼眶放射治疗重症格雷夫斯眼病的有效性和耐受性比较：一项前瞻性、单盲、随机研究的结果
J Clin Endocrinol Metab. 2001 Aug;86(8):3562-7. doi: 10.1210/jcem.86.8.7737.
7
Therapeutic responses to corticosteroids in Graves' ophthalmopathy.格雷夫斯眼病对皮质类固醇的治疗反应。
J Formos Med Assoc. 1996 Nov;95(11):833-8.
8
Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.静脉注射甲泼尼龙治疗格雷夫斯眼病。
BMJ. 1988 Dec 17;297(6663):1574-8. doi: 10.1136/bmj.297.6663.1574.
9
Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.甲泼尼龙治疗前后活动性格雷夫斯眼眶病患者血清中肝细胞生长因子（HGF）和白细胞介素-8（IL-8）的浓度。
J Endocrinol Invest. 2016 Jan;39(1):63-72. doi: 10.1007/s40618-015-0322-7. Epub 2015 Jun 11.
10
Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.Graves 眼病活动期和中重度患者的治疗进展。
Lancet Diabetes Endocrinol. 2017 Feb;5(2):134-142. doi: 10.1016/S2213-8587(16)30046-8. Epub 2016 Jun 23.
引用本文的文献
1
Future Projections in Thyroid Eye Disease.甲状腺眼病的未来预测。
J Clin Endocrinol Metab. 2022 Aug 8;107(Suppl_1):S47-S56. doi: 10.1210/clinem/dgac252.
本文引用的文献
1
Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.静脉注射甲泼尼龙治疗格雷夫斯眼病。
BMJ. 1988 Dec 17;297(6663):1574-8. doi: 10.1136/bmj.297.6663.1574.
2
Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.强化血浆置换继以免疫抑制治疗对重度格雷夫斯眼病的有益作用。
Acta Endocrinol (Copenh). 1986 Jan;111(1):30-8. doi: 10.1530/acta.0.1110030.
3
Increased serum pancreatic enzymes after treatment with methylprednisolone: possible evidence of subclinical pancreatitis.甲基泼尼松龙治疗后血清胰腺酶升高：亚临床胰腺炎的可能证据。
Br Med J (Clin Res Ed). 1985 Jul 6;291(6487):24. doi: 10.1136/bmj.291.6487.24.
4
Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.血浆置换成功治疗突眼和胫前黏液性水肿。
Br Med J. 1979 Feb 10;1(6160):374-6. doi: 10.1136/bmj.1.6160.374.
Zotero 插件